Software - Application
Compare Stocks
5 / 10Stock Comparison
SURG vs TMUS vs VZ vs LQDT vs T
Revenue, margins, valuation, and 5-year total return — side by side.
Telecommunications Services
Telecommunications Services
Specialty Retail
Telecommunications Services
SURG vs TMUS vs VZ vs LQDT vs T — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Telecommunications Services | Telecommunications Services | Specialty Retail | Telecommunications Services |
| Market Cap | $11M | $210.16B | $198.61B | $1.12B | $176.40B |
| Revenue (TTM) | $50M | $90.53B | $138.19B | $480M | $126.52B |
| Net Income (TTM) | $-42M | $10.54B | $17.17B | $30M | $21.41B |
| Gross Margin | -38.6% | 54.3% | 55.7% | 23.2% | 79.7% |
| Operating Margin | -78.8% | 20.4% | 21.2% | 8.4% | 19.4% |
| Forward P/E | — | 18.5x | 9.5x | 24.3x | 10.9x |
| Total Debt | $5M | $122.27B | $200.59B | $14M | $173.99B |
| Cash & Equiv. | $12M | $5.60B | $19.05B | $175M | $18.23B |
SURG vs TMUS vs VZ vs LQDT vs T — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| SurgePays, Inc. (SURG) | 100 | 3.6 | -96.4% |
| T-Mobile US, Inc. (TMUS) | 100 | 194.1 | +94.1% |
| Verizon Communicati… (VZ) | 100 | 82.1 | -17.9% |
| Liquidity Services,… (LQDT) | 100 | 634.9 | +534.9% |
| AT&T Inc. (T) | 100 | 108.5 | +8.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SURG vs TMUS vs VZ vs LQDT vs T
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SURG lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, TMUS doesn't own a clear edge in any measured category.
VZ is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 11 yrs, beta -0.11, yield 5.8%
- Lower P/E (9.5x vs 24.3x)
- 5.8% yield, 11-year raise streak, vs TMUS's 1.9%, (2 stocks pay no dividend)
LQDT carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 31.2%, EPS growth 38.1%, 3Y rev CAGR 19.4%
- 5.1% 10Y total return vs TMUS's 407.2%
- Lower volatility, beta 0.76, Low D/E 6.9%, current ratio 1.38x
- Beta 0.76, current ratio 1.38x
T ranks third and is worth considering specifically for quality.
- 16.9% margin vs SURG's -83.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 31.2% revenue growth vs SURG's -55.6% | |
| Value | Lower P/E (9.5x vs 24.3x) | |
| Quality / Margins | 16.9% margin vs SURG's -83.4% | |
| Stability / Safety | Beta 0.76 vs SURG's 1.30, lower leverage | |
| Dividends | 5.8% yield, 11-year raise streak, vs TMUS's 1.9%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +15.0% vs SURG's -78.9% | |
| Efficiency (ROA) | 8.0% ROA vs SURG's -242.4%, ROIC 60.8% vs -229.7% |
SURG vs TMUS vs VZ vs LQDT vs T — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SURG vs TMUS vs VZ vs LQDT vs T — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
LQDT leads in 2 of 6 categories
SURG leads 1 • VZ leads 1 • TMUS leads 0 • T leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — SURG and T each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
VZ is the larger business by revenue, generating $138.2B annually — 2743.4x SURG's $50M. T is the more profitable business, keeping 16.9% of every revenue dollar as net income compared to SURG's -83.4%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $50M | $90.5B | $138.2B | $480M | $126.5B |
| EBITDAEarnings before interest/tax | -$39M | $29.9B | $47.6B | $51M | $45.1B |
| Net IncomeAfter-tax profit | -$42M | $10.5B | $17.2B | $30M | $21.4B |
| Free Cash FlowCash after capex | -$26M | $10.7B | $19.8B | $78M | $10.6B |
| Gross MarginGross profit ÷ Revenue | -38.6% | +54.3% | +55.7% | +23.2% | +79.7% |
| Operating MarginEBIT ÷ Revenue | -78.8% | +20.4% | +21.2% | +8.4% | +19.4% |
| Net MarginNet income ÷ Revenue | -83.4% | +11.6% | +12.4% | +6.3% | +16.9% |
| FCF MarginFCF ÷ Revenue | -50.9% | +11.8% | +14.3% | +16.2% | +8.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.9% | +10.6% | +2.0% | +3.7% | +2.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +47.2% | -12.0% | -53.4% | +4.5% | -11.5% |
Valuation Metrics
SURG leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 8.3x trailing earnings, T trades at a 80% valuation discount to LQDT's 41.7x P/E. On an enterprise value basis, T's 7.4x EV/EBITDA is more attractive than LQDT's 21.2x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $11M | $210.2B | $198.6B | $1.1B | $176.4B |
| Enterprise ValueMkt cap + debt − cash | $4M | $326.8B | $380.2B | $964M | $332.2B |
| Trailing P/EPrice ÷ TTM EPS | -0.23x | 19.98x | 11.60x | 41.67x | 8.31x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 18.45x | 9.52x | 24.33x | 10.93x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.67x | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 10.13x | 7.99x | 21.19x | 7.37x |
| Price / SalesMarket cap ÷ Revenue | 0.18x | 2.38x | 1.44x | 2.36x | 1.40x |
| Price / BookPrice ÷ Book value/share | 0.70x | 3.71x | 1.88x | 5.78x | 1.41x |
| Price / FCFMarket cap ÷ FCF | — | 20.32x | 9.87x | 19.07x | 9.07x |
Profitability & Efficiency
LQDT leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
TMUS delivers a 17.8% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $-10 for SURG. LQDT carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to TMUS's 2.07x. On the Piotroski fundamental quality scale (0–9), LQDT scores 7/9 vs SURG's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -10.1% | +17.8% | +16.4% | +14.2% | +16.8% |
| ROA (TTM)Return on assets | -2.4% | +4.9% | +4.4% | +8.0% | +5.1% |
| ROICReturn on invested capital | -2.3% | +8.1% | +8.0% | +60.8% | +6.7% |
| ROCEReturn on capital employed | -177.3% | +9.8% | +8.8% | +17.3% | +6.8% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 6 | 4 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.30x | 2.07x | 1.90x | 0.07x | 1.35x |
| Net DebtTotal debt minus cash | -$7M | $116.7B | $181.5B | -$160M | $155.8B |
| Cash & Equiv.Liquid assets | $12M | $5.6B | $19.0B | $175M | $18.2B |
| Total DebtShort + long-term debt | $5M | $122.3B | $200.6B | $14M | $174.0B |
| Interest CoverageEBIT ÷ Interest expense | -40.65x | 5.33x | 4.39x | — | 4.97x |
Total Returns (Dividends Reinvested)
LQDT leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LQDT five years ago would be worth $14,784 today (with dividends reinvested), compared to $715 for SURG. Over the past 12 months, LQDT leads with a +15.0% total return vs SURG's -78.9%. The 3-year compound annual growth rate (CAGR) favors LQDT at 37.0% vs SURG's -49.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -67.4% | -2.2% | +19.7% | +22.5% | +5.1% |
| 1-Year ReturnPast 12 months | -78.9% | -21.2% | +13.6% | +15.0% | -6.2% |
| 3-Year ReturnCumulative with dividends | -86.9% | +40.4% | +45.9% | +157.1% | +67.0% |
| 5-Year ReturnCumulative with dividends | -92.8% | +45.5% | +2.8% | +47.8% | +29.9% |
| 10-Year ReturnCumulative with dividends | -99.1% | +407.2% | +41.6% | +508.2% | +41.9% |
| CAGR (3Y)Annualised 3-year return | -49.3% | +12.0% | +13.4% | +37.0% | +18.6% |
Risk & Volatility
Evenly matched — TMUS and LQDT each lead in 1 of 2 comparable metrics.
Risk & Volatility
TMUS is the less volatile stock with a -0.28 beta — it tends to amplify market swings less than SURG's 1.30 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LQDT currently trades 93.4% from its 52-week high vs SURG's 16.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.30x | -0.28x | -0.11x | 0.76x | -0.26x |
| 52-Week HighHighest price in past year | $3.45 | $261.56 | $51.68 | $38.83 | $29.79 |
| 52-Week LowLowest price in past year | $0.46 | $181.36 | $10.60 | $21.67 | $22.95 |
| % of 52W HighCurrent price vs 52-week peak | +16.2% | +74.2% | +91.1% | +93.4% | +84.8% |
| RSI (14)Momentum oscillator 0–100 | 39.9 | 45.5 | 49.3 | 81.6 | 38.9 |
| Avg Volume (50D)Average daily shares traded | 378K | 5.6M | 24.3M | 159K | 33.7M |
Analyst Outlook
VZ leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: TMUS as "Buy", VZ as "Hold", LQDT as "Buy", T as "Hold". Consensus price targets imply 30.8% upside for TMUS (target: $254) vs 9.5% for VZ (target: $52). For income investors, VZ offers the higher dividend yield at 5.76% vs TMUS's 1.88%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | — | $254.08 | $51.56 | $44.00 | $29.42 |
| # AnalystsCovering analysts | — | 54 | 60 | 14 | 62 |
| Dividend YieldAnnual dividend ÷ price | — | +1.9% | +5.8% | — | +4.5% |
| Dividend StreakConsecutive years of raises | — | 3 | 11 | 1 | 2 |
| Dividend / ShareAnnual DPS | — | $3.64 | $2.71 | — | $1.14 |
| Buyback YieldShare repurchases ÷ mkt cap | +5.6% | +4.7% | 0.0% | +1.4% | +2.6% |
LQDT leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). SURG leads in 1 (Valuation Metrics). 2 tied.
SURG vs TMUS vs VZ vs LQDT vs T: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SURG or TMUS or VZ or LQDT or T a better buy right now?
For growth investors, Liquidity Services, Inc.
(LQDT) is the stronger pick with 31. 2% revenue growth year-over-year, versus -55. 6% for SurgePays, Inc. (SURG). AT&T Inc. (T) offers the better valuation at 8. 3x trailing P/E (10. 9x forward), making it the more compelling value choice. Analysts rate T-Mobile US, Inc. (TMUS) a "Buy" — based on 54 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SURG or TMUS or VZ or LQDT or T?
On trailing P/E, AT&T Inc.
(T) is the cheapest at 8. 3x versus Liquidity Services, Inc. at 41. 7x. On forward P/E, Verizon Communications Inc. is actually cheaper at 9. 5x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — SURG or TMUS or VZ or LQDT or T?
Over the past 5 years, Liquidity Services, Inc.
(LQDT) delivered a total return of +47. 8%, compared to -92. 8% for SurgePays, Inc. (SURG). Over 10 years, the gap is even starker: LQDT returned +508. 2% versus SURG's -99. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SURG or TMUS or VZ or LQDT or T?
By beta (market sensitivity over 5 years), T-Mobile US, Inc.
(TMUS) is the lower-risk stock at -0. 28β versus SurgePays, Inc. 's 1. 30β — meaning SURG is approximately -565% more volatile than TMUS relative to the S&P 500. On balance sheet safety, Liquidity Services, Inc. (LQDT) carries a lower debt/equity ratio of 7% versus 2% for T-Mobile US, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SURG or TMUS or VZ or LQDT or T?
By revenue growth (latest reported year), Liquidity Services, Inc.
(LQDT) is pulling ahead at 31. 2% versus -55. 6% for SurgePays, Inc. (SURG). On earnings-per-share growth, the picture is similar: AT&T Inc. grew EPS 104. 0% year-over-year, compared to -273. 2% for SurgePays, Inc.. Over a 3-year CAGR, LQDT leads at 19. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SURG or TMUS or VZ or LQDT or T?
AT&T Inc.
(T) is the more profitable company, earning 17. 4% net margin versus -75. 1% for SurgePays, Inc. — meaning it keeps 17. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TMUS leads at 21. 2% versus -68. 6% for SURG. At the gross margin level — before operating expenses — T leads at 79. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SURG or TMUS or VZ or LQDT or T more undervalued right now?
On forward earnings alone, Verizon Communications Inc.
(VZ) trades at 9. 5x forward P/E versus 24. 3x for Liquidity Services, Inc. — 14. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TMUS: 30. 8% to $254. 08.
08Which pays a better dividend — SURG or TMUS or VZ or LQDT or T?
In this comparison, VZ (5.
8% yield), T (4. 5% yield), TMUS (1. 9% yield) pay a dividend. SURG, LQDT do not pay a meaningful dividend and should not be held primarily for income.
09Is SURG or TMUS or VZ or LQDT or T better for a retirement portfolio?
For long-horizon retirement investors, T-Mobile US, Inc.
(TMUS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 28), 1. 9% yield, +407. 2% 10Y return). Both have compounded well over 10 years (TMUS: +407. 2%, SURG: -99. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SURG and TMUS and VZ and LQDT and T?
These companies operate in different sectors (SURG (Technology) and TMUS (Communication Services) and VZ (Communication Services) and LQDT (Consumer Cyclical) and T (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SURG is a small-cap quality compounder stock; TMUS is a large-cap quality compounder stock; VZ is a mid-cap deep-value stock; LQDT is a small-cap high-growth stock; T is a mid-cap deep-value stock. TMUS, VZ, T pay a dividend while SURG, LQDT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Communication Services
- Market Cap > $100B
- Net Margin > 10%
- Dividend Yield > 1.8%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.